Medication-Assisted Treatment (MAT) for opioid addiction is available through the Opioid Treatment Programs (OTP) at all BCCS Treatment Centers in Delaware. Same-day medication is available in most cases. Everyone who presents is seen by staff, and same day support services are available to all.
Our Opioid Treatment Program utilizes methadone, Suboxone (buprenorphine and naloxone), and Subutex (buprenorphine) and is designed for individuals who may benefit from daily dosing and supervision in an OTP environment and for individuals who have previously used buprenorphine unsuccessfully in an OTP or OBOT setting.
In the Medication-Assisted Treatment (MAT) model, medication is used in combination with counseling and behavioral therapies. Medications can reduce the cravings and other symptoms associated with withdrawal from a substance by occupying receptors in the brain associated with using that drug (agonists or partial agonists), blocking the rewarding sensation that comes with using a substance (antagonists), or inducing negative feelings when a substance is taken. MAT is primarily used for the treatment of opioid use disorder.
Opioid agonist therapies with methadone or buprenorphine reduce the effects of opioid withdrawal, reduce cravings, and reduce the risk of relapse, and have also been shown to increase retention in treatment and reduce high-risk behaviors that lead to transmission of HIV and viral hepatitis, such as using opioids by injection.